> top > docs > PubMed:28249768 > annotations

PubMed:28249768 JSONTXT

Annnotations TAB JSON ListView MergeView

GoldHamster

Id Subject Object Predicate Lexical cue
T2 51-78 D048210 denotes Echinococcus multilocularis
T3 51-78 6211 denotes Echinococcus multilocularis
T4 94-102 D002589 denotes tapeworm
T5 94-102 UBERON:0018387 denotes tapeworm
T7 103-130 D048210 denotes Echinococcus multilocularis
T8 103-130 6211 denotes Echinococcus multilocularis
T9 157-180 C536591 denotes alveolar echinococcosis
T10 157-180 C536591 denotes alveolar echinococcosis
T15 192-210 D015047 denotes zoonotic infection
T16 192-210 D015047 denotes zoonotic infection
T19 396-399 D004285 denotes dog
T20 433-439 UBERON:3010325 denotes animal
T21 433-439 UBERON:0000468 denotes animal
T22 457-469 CHEBI:35443 denotes anthelmintic
T23 621-633 CHEBI:35443 denotes anthelmintic
T24 763-766 PR:Q0VIA1 denotes ten
T25 785-792 D004194 denotes disease
T26 785-792 D004194 denotes disease
T27 856-863 D004194 denotes disease
T28 856-863 D004194 denotes disease
T30 1168-1175 D004194 denotes disease
T31 1168-1175 D004194 denotes disease

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T1 80-247 DRI_Challenge denotes The parasitic tapeworm Echinococcus multilocularis is the causative agent of alveolar echinococcosis, a serious zoonotic infection present in Europe that can be fatal.
T2 248-480 DRI_Background denotes The United Kingdom currently has E. multilocularis free status but the possibility of introduction exists, most likely via an imported or returning dog or other deliberately introduced animal that has not had anthelmintic treatment.
T3 481-652 DRI_Approach denotes We have developed a model to predict the probability of successfully eliminating a focal outbreak of E. multilocularis using a programme of anthelmintic bait distribution.
T4 653-832 DRI_Approach denotes We investigated three different potential control programmes, each with 36 monthly campaigns commencing five, ten or 15 years after disease introduction over an area of 2827km(2).
T5 833-947 DRI_Approach denotes We assumed equilibrium disease prevalence of 30%, 40% and 55% based on the range of values reported across Europe.
T6 948-1121 DRI_Outcome denotes However, for all of these scenarios, equilibrium had not been reached at five to 15 years after introduction and simulated local prevalence values were between 0.5% and 28%.
T7 1122-1378 DRI_Approach denotes We found that it is possible to eliminate the disease with a 38%-86% success rate if control is started five years after introduction, dropping to 0% to 56% if control is delayed until 15 years after introduction, depending upon the prevalence equilibrium.
T8 1379-1484 DRI_Approach denotes We have also estimated the costs involved in these programmes to be from €7 to €12 million (2013 prices).

Goldhamster2_Cellosaurus

Id Subject Object Predicate Lexical cue
T1 22-23 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T2 182-183 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T3 277-280 CVCL_6758|Undefined_cell_line_type|Cricetulus griseus denotes has
T4 277-280 CVCL_E689|Transformed_cell_line|Homo sapiens denotes has
T5 371-373 CVCL_8754|Cancer_cell_line|Homo sapiens denotes an
T6 371-373 CVCL_H241|Cancer_cell_line|Homo sapiens denotes an
T7 445-448 CVCL_6758|Undefined_cell_line_type|Cricetulus griseus denotes has
T8 445-448 CVCL_E689|Transformed_cell_line|Homo sapiens denotes has
T9 481-483 CVCL_5M23|Cancer_cell_line|Mesocricetus auratus denotes We
T10 499-500 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T11 562-563 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T12 606-607 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T13 653-655 CVCL_5M23|Cancer_cell_line|Mesocricetus auratus denotes We
T14 725-727 CVCL_9087|Hybrid_cell_line|Homo sapiens,Mus musculus denotes 36
T15 763-766 CVCL_E063|Cancer_cell_line|Homo sapiens denotes ten
T16 811-813 CVCL_8754|Cancer_cell_line|Homo sapiens denotes an
T17 811-813 CVCL_H241|Cancer_cell_line|Homo sapiens denotes an
T18 833-835 CVCL_5M23|Cancer_cell_line|Mesocricetus auratus denotes We
T19 878-880 CVCL_J925|Hybridoma|Mus musculus denotes 30
T20 883-885 CVCL_IW90|Cancer_cell_line|Mus musculus denotes 40
T21 1122-1124 CVCL_5M23|Cancer_cell_line|Mesocricetus auratus denotes We
T22 1181-1182 CVCL_6479|Finite_cell_line|Mus musculus denotes a
T23 1379-1381 CVCL_5M23|Cancer_cell_line|Mesocricetus auratus denotes We
T24 1406-1411 CVCL_9491|Cancer_cell_line|Homo sapiens denotes costs
T25 1471-1475 CVCL_G029|Transformed_cell_line|Homo sapiens denotes 2013